Minimal Residual Disease + B-Cell Acute Lymphoblastic Leukemia
1 clinical trials · Condition
◉ Watch Minimal Residual Disease + B-Cell Acute Lymphoblastic Leukemia
| Record | Firm | Date |
|---|---|---|
| A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia (NCT07134088) | Amgen | 2025-12-08 |
Track Minimal Residual Disease + B-Cell Acute Lymphoblastic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.